Clinical Trials · NCT07299084
A Study to Evaluate the Effect of Fasting Duration and Tirzepatide Withholding on the Amount of Food and Fluid in the Stomach in Participants With Type 2 Diabetes Mellitus and Participants With Overweight or Obesity Without Type 2 Diabetes Mellitus
- Phase
- Phase 1
- Recruitment status
- Active Not Recruiting
- Sponsor
- Eli Lilly and Company
- Enrollment
- 40
- Start date
- Jan 2026
- Locations
- 1 site, Singapore
- Primary endpoint
- Percentage of Participants with Lack of Gastric Content Retention Post-Solid Test Meal